Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Feb;44(2):119–125. doi: 10.1136/jcp.44.2.119

Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin.

S S Banerjee 1, J Heald 1, M Harris 1
PMCID: PMC496972  PMID: 1650796

Abstract

In seven of 12 cases of Ber-H2 (Ki-1) positive anaplastic large cell non-Hodgkin's lymphoma (Ki-1 ALCL) disease remained localised to skin, and in five there was extracutaneous spread. Four patients had histological evidence of pre-existing or coexisting mycosis fungoides, and three patients had a long standing history of eczema or ichthyosis. In two cases the presence of a T phenotype was shown in frozen sections, and in a further six cases a T phenotype was firmly established in paraffin wax sections. Four patients died less than one year after presentation (two with disseminated lymphoma; two from other causes); one died at five years with widespread lymphoma and the remaining seven cases were alive one to 14 1/2 years after presentation. Three of the four patients with associated mycosis fungoides had prolonged survival, contrary to the findings of previous reports which suggest secondary Ki-1 ALCL behaves aggressively. The recognition of these tumours is important because of their relatively good prognosis. The diagnosis can be readily substantiated immunohistochemically, using a simple panel of antibodies.

Full text

PDF
119

Images in this article

121Image
on p.121
121Image
on p.121
122Image
on p.122
122Image
on p.122
122Image
on p.122
123Image
on p.123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnarsson B. A., Kadin M. E. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol. 1988 Apr;12(4):264–274. doi: 10.1097/00000478-198804000-00002. [DOI] [PubMed] [Google Scholar]
  2. Brandtzaeg P., Jones D. B., Flavell D. J., Fagerhol M. K. Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J Clin Pathol. 1988 Sep;41(9):963–970. doi: 10.1136/jcp.41.9.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chan J. K., Ng C. S., Hui P. K., Leung T. W., Lo E. S., Lau W. H., McGuire L. J. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology. 1989 Jul;15(1):11–34. doi: 10.1111/j.1365-2559.1989.tb03038.x. [DOI] [PubMed] [Google Scholar]
  4. Chott A., Kaserer K., Augustin I., Vesely M., Heinz R., Oehlinger W., Hanak H., Radaszkiewicz T. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol. 1990 May;14(5):439–448. doi: 10.1097/00000478-199005000-00003. [DOI] [PubMed] [Google Scholar]
  5. Delsol G., Al Saati T., Gatter K. C., Gerdes J., Schwarting R., Caveriviere P., Rigal-Huguet F., Robert A., Stein H., Mason D. Y. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988 Jan;130(1):59–70. [PMC free article] [PubMed] [Google Scholar]
  6. Flynn K. J., Dehner L. P., Gajl-Peczalska K. J., Dahl M. V., Ramsay N., Wang N. Regressing atypical histiocytosis: a cutaneous proliferation of atypical neoplastic histiocytes with unexpectedly indolent biologic behavior. Cancer. 1982 Mar 1;49(5):959–970. doi: 10.1002/1097-0142(19820301)49:5<959::aid-cncr2820490521>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  7. Hall P. A., D'Ardenne A. J., Butler M. G., Habeshaw J. R., Stansfeld A. G. New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol. 1987 Feb;40(2):151–156. doi: 10.1136/jcp.40.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hall P. A., d'Ardenne A. J., Stansfeld A. G. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma. Histopathology. 1988 Aug;13(2):161–169. doi: 10.1111/j.1365-2559.1988.tb02021.x. [DOI] [PubMed] [Google Scholar]
  9. Hanson C. A., Jaszcz W., Kersey J. H., Astorga M. G., Peterson B. A., Gajl-Peczalska K. J., Frizzera G. True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis. Br J Haematol. 1989 Oct;73(2):187–198. doi: 10.1111/j.1365-2141.1989.tb00251.x. [DOI] [PubMed] [Google Scholar]
  10. Hansson G. K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989 Jul;135(1):169–175. [PMC free article] [PubMed] [Google Scholar]
  11. Headington J. T., Roth M. S., Schnitzer B. Regressing atypical histiocytosis: a review and critical appraisal. Semin Diagn Pathol. 1987 Feb;4(1):28–37. [PubMed] [Google Scholar]
  12. Hsu S. M., Jaffe E. S. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol. 1984 Jul;82(1):29–32. doi: 10.1093/ajcp/82.1.29. [DOI] [PubMed] [Google Scholar]
  13. Kadin M. E., Sako D., Berliner N., Franklin W., Woda B., Borowitz M., Ireland K., Schweid A., Herzog P., Lange B. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986 Nov;68(5):1042–1049. [PubMed] [Google Scholar]
  14. Kadin M., Nasu K., Sako D., Said J., Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985 May;119(2):315–325. [PMC free article] [PubMed] [Google Scholar]
  15. Kaudewitz P., Stein H., Dallenbach F., Eckert F., Bieber K., Burg G., Braun-Falco O. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol. 1989 Aug;135(2):359–367. [PMC free article] [PubMed] [Google Scholar]
  16. Kurtin P. J., Pinkus G. S. Leukocyte common antigen--a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Hum Pathol. 1985 Apr;16(4):353–365. doi: 10.1016/s0046-8177(85)80229-x. [DOI] [PubMed] [Google Scholar]
  17. Lindholm J. S., Barron D. R., Williams M. E., Swerdlow S. H. Ki-1-positive cutaneous large cell lymphoma of T cell type: report of an indolent subtype. J Am Acad Dermatol. 1989 Feb;20(2 Pt 2):342–348. doi: 10.1016/s0190-9622(89)70043-8. [DOI] [PubMed] [Google Scholar]
  18. Macaulay W. L. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant. Arch Dermatol. 1968 Jan;97(1):23–30. doi: 10.1001/archderm.97.1.23. [DOI] [PubMed] [Google Scholar]
  19. Mason D. Y., Krissansen G. W., Davey F. R., Crumpton M. J., Gatter K. C. Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens. J Clin Pathol. 1988 Feb;41(2):121–127. doi: 10.1136/jcp.41.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nasu K., Said J., Vonderheid E., Olerud J., Sako D., Kadin M. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol. 1985 Jun;119(3):436–447. [PMC free article] [PubMed] [Google Scholar]
  21. Norton A. J., Isaacson P. G. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. J Clin Pathol. 1987 Dec;40(12):1405–1412. doi: 10.1136/jcp.40.12.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Norton A. J., Ramsay A. D., Smith S. H., Beverley P. C., Isaacson P. G. Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. J Clin Pathol. 1986 Apr;39(4):399–405. doi: 10.1136/jcp.39.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Connor N. T., Stein H., Gatter K. C., Wainscoat J. S., Crick J., Al Saati T., Falini B., Delsol G., Mason D. Y. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology. 1987 Jul;11(7):733–740. doi: 10.1111/j.1365-2559.1987.tb02687.x. [DOI] [PubMed] [Google Scholar]
  24. Pallesen G. The diagnostic significance of the CD30 (Ki-1) antigen. Histopathology. 1990 Apr;16(4):409–413. doi: 10.1111/j.1365-2559.1990.tb01151.x. [DOI] [PubMed] [Google Scholar]
  25. Pulford K. A., Rigney E. M., Micklem K. J., Jones M., Stross W. P., Gatter K. C., Mason D. Y. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989 Apr;42(4):414–421. doi: 10.1136/jcp.42.4.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ralfkiaer E., Delsol G., O'Connor N. T., Brandtzaeg P., Brousset P., Vejlsgaard G. L., Mason D. Y. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol. 1990 Jan;160(1):9–17. doi: 10.1002/path.1711600105. [DOI] [PubMed] [Google Scholar]
  27. Rilke F., Giardini R., Lombardi L. Recurrent atypical cutaneous histiocytosis. Pathol Annu. 1985;20(Pt 2):29–58. [PubMed] [Google Scholar]
  28. Salhany K. E., Cousar J. B., Greer J. P., Casey T. T., Fields J. P., Collins R. D. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol. 1988 Aug;132(2):265–277. [PMC free article] [PubMed] [Google Scholar]
  29. Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 1982 Sep 2;299(5878):65–67. doi: 10.1038/299065a0. [DOI] [PubMed] [Google Scholar]
  30. Schwarting R., Gerdes J., Dürkop H., Falini B., Pileri S., Stein H. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood. 1989 Oct;74(5):1678–1689. [PubMed] [Google Scholar]
  31. Smoller B. R., McNutt N. S., Hsu A. HMB-45 recognizes stimulated melanocytes. J Cutan Pathol. 1989 Apr;16(2):49–53. doi: 10.1111/j.1600-0560.1989.tb00010.x. [DOI] [PubMed] [Google Scholar]
  32. Stein H., Gerdes J., Schwab U., Lemke H., Mason D. Y., Ziegler A., Schienle W., Diehl V. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer. 1982 Oct 15;30(4):445–459. doi: 10.1002/ijc.2910300411. [DOI] [PubMed] [Google Scholar]
  33. Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985 Oct;66(4):848–858. [PubMed] [Google Scholar]
  34. Sterry W., Korte B., Schubert C. Pleomorphic T-cell lymphoma and large-cell anaplastic lymphoma of the skin. A morphological, immunophenotypical, and ultrastructural study of two typical cases. Am J Dermatopathol. 1989 Apr;11(2):112–123. doi: 10.1097/00000372-198911020-00002. [DOI] [PubMed] [Google Scholar]
  35. Stross W. P., Warnke R. A., Flavell D. J., Flavell S. U., Simmons D., Gatter K. C., Mason D. Y. Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. J Clin Pathol. 1989 Sep;42(9):953–961. doi: 10.1136/jcp.42.9.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Suchi T., Lennert K., Tu L. Y., Kikuchi M., Sato E., Stansfeld A. G., Feller A. C. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol. 1987 Sep;40(9):995–1015. doi: 10.1136/jcp.40.9.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sugimoto H., Nakayama F., Yamauchi T., Tokura Y., Iwatsuki K., Takigawa M., Yamada M., Maeda M. Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient. Arch Dermatol. 1988 Mar;124(3):405–408. doi: 10.1001/archderm.124.3.405. [DOI] [PubMed] [Google Scholar]
  38. Tashiro K., Kikuchi M., Takeshita M., Yoshida T., Ohshima K. Clinicopathological study of Ki-1-positive lymphomas. Pathol Res Pract. 1989 Oct;185(4):461–467. doi: 10.1016/S0344-0338(89)80063-9. [DOI] [PubMed] [Google Scholar]
  39. Weinman V. F., Ackerman A. B. Lymphomatoid papulosis. A critical review and new findings. Am J Dermatopathol. 1981 Summer;3(2):129–163. doi: 10.1097/00000372-198100320-00004. [DOI] [PubMed] [Google Scholar]
  40. Weiss L. M., Wood G. S., Trela M., Warnke R. A., Sklar J. Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med. 1986 Aug 21;315(8):475–479. doi: 10.1056/NEJM198608213150802. [DOI] [PubMed] [Google Scholar]
  41. White R. M., Patterson J. W. Cutaneous involvement in Hodgkin's disease. Cancer. 1985 Mar 1;55(5):1136–1145. doi: 10.1002/1097-0142(19850301)55:5<1136::aid-cncr2820550532>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  42. Willemze R., Meyer C. J., Van Vloten W. A., Scheffer E. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol. 1982 Aug;107(2):131–144. doi: 10.1111/j.1365-2133.1982.tb00331.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES